Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT07107971
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Registry
-
NCT07107971
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT07107971. Randomized; no masking; primary purpose treatment. Start 2025-11-04 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques
- Acronym
- DELETE-LRP
- Condition
- Coronary Artery Disease
- Condition
- Atheroscleroses
- Condition
- Cardiovascular Disease
- Condition
- Vulnerable Coronary Plaques
- Condition
- Vulnerable Plaque
- Condition
- Lipid-Rich Atherosclerosis of Coronary Artery
- Condition
- Acute Coronary Syndromes (ACS)
- Intervention (Device)
- Paclitaxel-eluting balloon
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Record details
- Record id
cardio:ct-nct07107971- Content hash
cadca904f12abedf65c2771045d356f428128031c81f829b3977f5c4d48edd7e